Agile Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AGRX and buy or sell other stocks, ETFs, and their options commission-free!About AGRX
Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patches. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive.
CEORobert Spina
CEORobert Spina
Employees—
Employees—
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded1997
Founded1997
Employees—
Employees—
AGRX Key Statistics
Market cap10.43M
Market cap10.43M
Price-Earnings ratio-0.47
Price-Earnings ratio-0.47
Dividend yield—
Dividend yield—
Average volume88.98K
Average volume88.98K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.63
52 Week high$2.63
52 Week low$0.20
52 Week low$0.20
Stock Snapshot
As of today, Agile Therapeutics(AGRX) shares are valued at $1.35. The company's market cap stands at 10.43M, with a P/E ratio of -0.47.
Agile Therapeutics(AGRX) stock opened on 2025-12-18 at —. The price climbed to — and dipped to —.
Agile Therapeutics(AGRX) shares are trading with a volume of 0, against a daily average of 88.98K.
In the last year, Agile Therapeutics(AGRX) shares hit a 52-week high of $2.63 and a 52-week low of $0.20.
In the last year, Agile Therapeutics(AGRX) shares hit a 52-week high of $2.63 and a 52-week low of $0.20.
People also own
Based on the portfolios of people who own AGRX. This list is generated using Robinhood data, and it’s not a recommendation.